[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.142.229. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1989

Interleukin 1

Author Affiliations

From the Department of Medicine, Division of Dermatology, McMaster University, Hamilton, Canada.

Arch Dermatol. 1989;125(5):679-682. doi:10.1001/archderm.1989.01670170093017
Abstract

• The last decade has witnessed a remarkable expansion in the understanding of the skin as an immunologic organ. A prime example of this is the discovery that keratinocytes can synthesize and secrete immunoregulatory and proinflammatory glycoproteins termed cytokines. Initial studies focused on interleukin 1-like molecules produced by keratinocytes, initially termed epidermal cell-derived thymocyte activating factor (ETAF). It is now clear that the functional activities described by the term ETAF are composed mainly of interleukin 1α and interleukin 1β, although other epidermal cytokines may contribute to the biologic activity. The biologic properties of interleukin 1 are the basis of this review.

(Arch Dermatol. 1989;125:679-682)

×